Contact UsHome

POC Meeting, Webinars, and Events Calendar

2019 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

Starting a POC Group >

POCC of the Year >

POC Vendors >

Publications >

POC Procedures >

POC Meeting News


NACB Guidelines


What's Happening in POCT

POCT Resources


Chat with POCCs

POC Groups
Alabama Arizona Bay Area (CA)  Central Florida 
Georgia  Heart of America  KEYPOCC Louisiana 
New Jersey  North Carolina North Country (MN) North Texas
Northwest (OR) Ohio  Rocky Mountain San Diego 
South Carolina Southern California  Southwest Florida  Southwest 
Tennessee  Texas Gulf Coast Virginia 3Rivers (Western PA)

Personal Paradox and More: POC Pitfalls
CAP Today, November 2019, By Charna Albert

Point-of-care testing makes up only about 10 percent of all laboratory testing but the aggravation factor and number of people involved far exceeds that, said Deborah A. Perry, MD, medical director of pathology at Methodist Hospital in Omaha, Neb., speaking at CAP19 and calling POC testing “a whole different world.”

In a session titled “Point-of-care testing pitfalls: what you don’t know can hurt you,” Dr. Perry and Brad S. Karon, MD, PhD, professor of laboratory medicine and pathology and co-director of the point-of-care program at Mayo Clinic, used scenarios to illustrate point-of-care testing risks and how to mitigate them.

“Initially, people kind of let the point-of-care side of the world go to the medical technologists, and the laboratory medical directors hoped we wouldn’t have to worry about it too much,” said Dr. Perry. “But as we have watched the point-of-care testing volume and test mix grow, and have undergone on-site inspections, we now know that as the medical director it’s your responsibility to make sure it’s done right. We’re here to tell you some of the frightful things that have happened to us in point of care, and hopefully help you avoid those,” Dr. Perry added.

Here is scenario No. 1: Nursing performs competency assessment for POC on career day...
Read more

Twenty Years After 'To Err Is Human'
Leapfrog Group Highlights Progress on
Patient Saftey, Transparency
Organization seeing fewer deaths from preventable errors it monitors
DAVID RATHS NOVEMBER 2019 | Healthcare Innovation

Coinciding with the 20th anniversary of the Institute of Medicine’s groundbreaking “To Err is Human” report, the Leapfrog Group’s fall 2019 Hospital Safety Grades highlight progress on patient safety. The Leapfrog Hospital Safety Grade is a bi-annual grading assigning “A” through “F” letter grades to general acute-care hospitals in the U.S. It is the nation’s only rating focused entirely on patient safety—preventable errors, accidents, injuries and infections.

The “To Err is Human” report revealed nearly 100,000 lives are lost every year due to preventable medical errors. Subsequent research suggests the number may be twice as high, according to the Leapfrog Group.

“In stark contrast to 20 years ago..." Read more >

POCT Professional Certification Validates Expertise in the Field

At Aculabs, an East Brunswick, New Jersey-based company that services long-term and acute-care facilities, laboratory director Rita Khoury, MD, DABCC, FAACC, CPP, spends her days overseeing testing for these entities, with the goal of turning around test results quickly to help reduce hospital readmission among residents. This includes a point-of-care testing (POCT) program started in 2014, which became the first and only laboratory program in the Mid-Atlantic that can help maintain, train and integrate bedside blood analysis.

CPP diplomates at the CPOCT Division & Awards Meeting in August at the 2019 American Association for Clinical Chemistry (AACC) Annual Scientific Meeting & Clinical Lab Expo (Anaheim, CA); from left to right: Jane Tansiongco, Christa Williams, Peggy Mann, Debra Petracco, Lilah Evans, Richard Lambert, Rita Khoury, Gayle Roca, Leh Chang, Darlene Paskovics, Sheryl Lynn Brooks and Linda Kuhn.

So when Khoury saw an email from AACC last year announcing its new POCT Professional Certification, she was very excited, and applied immediately. Khoury became one of the first POCT professionals to take the exam last November, and soon added the CPP (certified point-of-care testing professional) initials to her name. Read more >

2019 CAP Accreditation Checklists Available

Some highlights of this edition’s changes include the addition of a new checklist requirement in the chemistry checklist on opiate testing; the addition of a new checklist requirement in the transfusion medicine checklist to align with the FDA on the labeling of red blood cells with historical antigen typing; the revision of multiple checklist requirements in the histocompatibility checklist to be compliant with the Foundation for the Accreditation of Cellular Therapy standards; and a revision of the biorepository checklist for biorepository laboratories to be consistent with CLIA regulations.

CAP hosted a webinar on October 16 designed to help users manage the changes in this edition. “2019 CAP Accreditation Checklist Updates: Changes That Matter” featuring speakers William West, MD, and Harris Goodman, MD, both members of the Checklists Committee.

Visit the Checklist Page (note: This new 2019 accreditation checklists web page will be inactive soon. Log in to e-LAB Solutions Suite (ELSS) to access your laboratory’s customized checklists).

See the POCT Checklist

New test diagnoses Lyme disease within 15 mins

MLO, October 2019

Some 300,000 people in the U.S. are diagnosed with Lyme disease every year. Caused by Borrelia burgdorferi and transmitted by the bite of infected Ixodes ticks, the disease if left untreated can cause serious neurologic, cardiac, and/or rheumatologic complications.

Current testing for Lyme disease, called the standard 2-tiered approach or the STT, involves running two complex assays (ELISA and western blot) to detect antibodies against the bacterium, and requires experienced personnel in a lab, and a few hours to carry out and interpret. A team led by Sam Sia, professor of biomedical engineering at Columbia Engineering, has developed a rapid microfluidic test that can detect Lyme disease with similar performance as the STT in a much shorter time—15 minutes. Read more >

The New Wave of Diabetes Management

Monitoring Technologies Surge as Disease Prevalence Mounts
By Whitney J. Palmer, Clinical Laboratory News, October 2019

Big data and bioengineering advances are fueling rapid changes in diabetes technologies, which offer the promise of better self-management and quality of life for individuals with the disease, and easier care oversight by physicians. With the incidence of diabetes rising, these innovations are coming into use when “the ability of an individual living with diabetes to have human-to-human contact with their healthcare provider is not keeping pace with the number of people developing diabetes,” according to a recent review. Read more >

Click here for more stories in our Article Archives...


Last updated: 11/09/2018 Questions or corrections: 2016  BACK TO TOP